Sat.Jan 30, 2021 - Fri.Feb 05, 2021

article thumbnail

White paper reveals pathway for digital therapeutics use in Italy

pharmaphorum

A white paper has outlined a pathway that could allow Italy to realise the potential of digital therapeutics (DTx). The official journal of the Smith Kline Foundation, Tendenze Nuove, has published the paper entitled “Digital Therapeutics, an Opportunity for Italy” earlier this month. The book features insights and recommendations from 40 leading experts in the field, who hope that Italy will begin to follow in the footsteps of early adopters of digital therapeutics such as Germany, France and

article thumbnail

Family cancer experience informs eHealth company

Outsourcing Pharma

The founder of Andaman7âs leukemia diagnosis, and his sonâs experience with bone cancer, have helped inform the firm's tech and patient-centric approach.

120
120
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Webinar Recap – Video, Voice, and Virtual: Applying New Digital Technology to Enhance Customer Experience with PMN

Pharma Marketing Network

Moderator and Panelists: Amy Turnquist , EVP, Digital, eHealthcare Solutions (Moderator). Ryan Billings , U.S. Oncology Digital Marketing & Customer Experience at GSK. Desiree Priestley , Director, Patient Support Strategy & Insights at Otsuka America Pharmaceutical. Kristen Palmer Winters , Customer Experience (CX), Americas Hub, Digital & Commercial Innovation, Bayer.

98
article thumbnail

Olympus Supports Dissemination of Endoscopic Procedures for Colorectal Cancer in Russia

Pharma Mirror

Olympus Corporation (Director, Representative Executive Officer, President and CEO: Yasuo Takeuchi) announced today that it has been selected(1) by Japan’s Ministry of Health, Labour and Welfare (MHLW) to implement the Japan-Russia Medical Cooperation Promotion Project in the field of endoscopy for the fiscal year ending March, 2021. Under the project, Olympus will promulgate gastrointestinal endoscopic/laparoscopic techniques in support of a five-year oncology plan launched by the Russian

52
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Not every cough is COVID – MSD UK’s lung cancer campaign

pharmaphorum

For World Cancer Day, David Long, business unit director of Oncology at MSD UK tells pharmaphorum about the company’s ‘Do It Yourself’ campaign launched in the North East to raise awareness of lung cancer symptoms. As COVID cases surged last year, lung cancer referrals dropped in the UK, causing alarm to the UK Lung Cancer Coalition (UKLCC), an alliance of the UK’s leading lung cancer experts, senior NHS professionals, charities, and healthcare companies.

article thumbnail

UK trial explores impact of combining different COVID-19 vaccines

Outsourcing Pharma

An Oxford University trial, a world first, is looking at whether inoculating volunteers with doses of different combinations of two currently approved COVID-19 vaccines is effective.

More Trending

article thumbnail

Two Immigrants, One Unique Plan For A Biopharma

Pharma Mirror

The American Dream is why the United States is considered the “land of opportunity,” and why for centuries immigrants have flocked to our shores seeking their fortunes. Guo-Liang Yu, Ph.D., (China), and Sanjeev Redkar, Ph.D., (India), came to the U.S. in the 1980s. By anyone’s reasonable measure, both have achieved the American Dream.

article thumbnail

Why we need the human element of remote clinical trials

pharmaphorum

Over the last year, we’ve noticed that “connectivity” doesn’t always equate to “connected” – and that’s just as true in the realm of clinical trials as it is in our personal lives. Amanda Barrell reports from a panel at the Patients as Partners Europe conference on remote clinical trials. Decentralised trials have been growing in popularity in recent years, and the COVID-19 pandemic has served to accelerate that progress.

Hospitals 132
article thumbnail

Lung cancer community severely impacted by COVID: report

Outsourcing Pharma

A report from the World Economic Forum and Lung Ambition Alliance outlines the impacts the pandemic is having on lung cancer diagnoses and treatment.

98
article thumbnail

Guest Episode – DarshanTalks: Marketing and Evolving Patient Centricity – February 1, 2021

Pharma Marketing Network

[link]. The Pharma Marketing Podcast is pleased to present this special guest episode from our friend and Editorial Advisory Board member Darshan Kulkarni, Marketing and Evolving Patient Centricity – January 27, 2021. The discussion between host, Darshan Kulkarni, Head of Growth at Gentem Health, Omar Khateeb, and Director of DTC & HCP Marketing at Bausch Health, Keith Peiper discusses the importance of tracking patients and their journeys, educating patients, and building patient tru

52
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

I Holland to Deliver a Free Tooling Maintenance Webinar Series

Pharma Mirror

Ensuring punches and dies are kept in optimum condition is essential to produce high quality tablets. As the demand for pharmaceutical tablets increases, the importance for proficient tool maintenance becomes even more important. To help companies understand the processes involved, I Holland, leaders in the manufacture of tablet tooling, will launch a free seven month webinar series, with the first presentation taking place at 2pm GMT on 25th February 2021.

52
article thumbnail

Almirall, Happify partner on digital tool for psoriasis mental health

pharmaphorum

It’s well recognised that people with psoriasis can develop depression or anxiety, particularly in moderate or severe cases where a sizeable part of the body can have skin lesions. Now, drugmaker Almirall and digital health firm Happify are working on a tool to support mental health in these patients. Almirall is a specialist in psoriasis therapies with drugs like Skilarence (dimethyl fumarate) and Ilumetri (tildrakizumab), while Happify’s app is designed to drive away negative thoughts through

124
124
article thumbnail

Merck Digital Ethics Advisory Panel tackles tech questions

Outsourcing Pharma

The panel is intended to address ethical matters that arise around evolving data and digital conduct for all of its various business sectors.

95
article thumbnail

Guest Episode – DarshanTalks: Marketing and Evolving Patient Centricity – February 1, 2021

Pharma Marketing Network

The Pharma Marketing Podcast is pleased to present this special guest episode from our friend and Editorial Advisory Board member Darshan Kulkarni, Marketing and Evolving Patient Centricity – January 27, 2021. The discussion between host, Darshan Kulkarni, Head of Growth at Gentem Health, Omar Khateeb, and Director of DTC & HCP Marketing at Bausch Health, Keith Peiper discusses the importance of tracking patients and their journeys, educating patients, and building patient trust.

52
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Olympus Supports Dissemination of Endoscopic Procedures for Colorectal Cancer in Russia

Pharma Mirror

Olympus Corporation (Director, Representative Executive Officer, President and CEO: Yasuo Takeuchi) announced today that it has been selected(1) by Japan’s Ministry of Health, Labour and Welfare (MHLW) to implement the Japan-Russia Medical Cooperation Promotion Project in the field of endoscopy for the fiscal year ending March, 2021. Under the project, Olympus will promulgate gastrointestinal endoscopic/laparoscopic techniques in support of a five-year oncology plan launched by the Russian

52
article thumbnail

AstraZeneca to supply nine million more vaccines to EU

pharmaphorum

The diplomatic row that broke out last week over the supply of AstraZeneca’s vaccine to Europe appears to have cooled after the UK pharma agreed to supply an extra nine million doses. At the end of last week, the European Commission was forced into an embarrassing U-Turn when it tried to impose restrictions on COVID-19 vaccines exported from the bloc.

Vaccines 107
article thumbnail

Parexel, Signify join forces to boost trial inclusivity

Outsourcing Pharma

The firms will work to develop solutions centered on increasing diversity and inclusivity in clinical research, and addressing healthcare disparities.

87
article thumbnail

Winning 2021: How to Save, Invest, and Earn More This Year

That Frugal Pharmacist

2020 was a year like no other. Like many others, we’re looking forward to leaving this year behind and having a fresh start in 2021. And there is no better time than the New Year to start making changes in your life and create new financial habits. If you want to change your financial picture, … Winning 2021: How to Save, Invest, and Earn More This Year Read More ».

52
article thumbnail

3 Tips to Optimize Your Site’s Images

Mission-Driven Marketing Blog

Organizations with strong inbound marketing initiatives spend a lot of time optimizing their website content.

52
article thumbnail

UK biotech investment at record levels amid COVID-19

pharmaphorum

New figures have confirmed that the UK’s biotech sector received a massive boost from the COVID-19 pandemic last year, with investment levels soaring to £2.8 billion ($3.8 billion) from a level of £1.3 billion in 2019. That makes 2020 a new record year for the sector, exceeding the previous investment high of £2.2 billion in 2018, according to the latest BioIndustry Association (BIA) and Clarivate report, and represents a 1,000% increase on 2012.

Vaccines 106
article thumbnail

Super Bowl player donates to help fund cancer research

Outsourcing Pharma

William Gholston, with the Tampa Bay Buccaneers football team, is donating to the Moffitt Cancer Center to fund research into cancer treatment disparities.

82
article thumbnail

New analysis backs safety, efficacy of AZ/Oxford COVID-19 jab

Pharma Times

The data show 100% protection against severe disease, hospitalisation and death, greater vaccine efficacy with an inter-dose interval of 12 weeks or more, and the potential for reduced asymptomatic transmission

article thumbnail

Ziprasidone With Or Without Food?

Med Ed 101

Here’s a case scenario where the clinical outcome may have hinged on taking ziprasidone with or without food. KD is a 33-year-old male who was diagnosed with schizophrenia. Olanzapine and risperidone were the first antipsychotics that were tried to help alleviate the positive symptoms (hallucinations, delusions, etc.) of schizophrenia. Olanzapine led to a quick uptick […].

40
article thumbnail

A Message to Pharma CIOs: Optimizing Salesforce Improves Security and Compliance

pharmaphorum

By Jennifer Mercer , CEO of Metazoa. Jennifer Mercer is Co-founder and CEO of Metazoa, developers of Snapshot, an admin and developer tool for companies with complex Salesforce orgs that is used by over 60% of Fortune 100 companies. . Salesforce org management is usually not the headliner for CIOs and CTOs looking to catch up on executive-level trends and issues pertaining to technology.

article thumbnail

AI-based image redaction guards trial patient privacy

Outsourcing Pharma

Bioclinicaâs Image Redact AI tool enables trials to edit sensitive information from videos, photos and PDFs to ensure compliance and safeguard patient data.

58
article thumbnail

NICE green light for GSK's Nucala

Pharma Times

Final guidance on the drug's use to treat patients with severe eosinophilic asthma on the NHS has now been published

46
article thumbnail

5 Best Non-Drowsy Hayfever Tablets

Druggist

Hayfever, also known as seasonal allergic rhinitis is a common condition which occurs mainly during spring and summer seasons. Hayfever symptoms happen in response to allergens such as tree or grass pollen and may include runny nose, sneezing and watery eyes. Thankfully there are few non-drowsy hayfever tablets, which I am going to review. Non-drowsy antihistamines, which can be purchased over the counter in the UK include: Cetirizine.

52
article thumbnail

UK patient group warns COVID could limit access to Novartis’ new eye drug

pharmaphorum

NICE has recommended regular NHS funding for Novartis’ long-acting eye drug Beovu (brolucizumab) in England and Wales – but a patient group warned that access could be limited until the pandemic recedes because of disruption to ophthalmology clinics. In final guidance NICE said trials have shown Novartis’ Beovu has similar efficacy in wet advanced macular degeneration (AMD) to rival Eylea (aflibercept) from Bayer/Regeneron and Novartis predecessor Lucentis (ranibizumab).

article thumbnail

Use of medical imaging in clinical trials expanding

Outsourcing Pharma

While the technology has been found mostly in dermatological applications, its use in studies is expanding, according to Illingworth Research Group.

61
article thumbnail

Millions could benefit from genetic screening before prescribing, new research finds

Pharma Times

Research led by the University of East Anglia in collaboration Boots UK and Leiden University

47
article thumbnail

CHMP clears way for EU approval of Novartis’ MS drug

pharmaphorum

Novartis’ multiple sclerosis drug has been given the green light by the European Medicines Agency’s CHMP scientific committee, paving the way for a likely approval in the coming weeks. Kesimpta (ofatumumab) started life as an oncology drug and was first developed by Genmab and licensed to GlaxoSmithKline who marketed under the brand name Arzerra to treat chronic lymphocytic leukaemia.

FDA 96
article thumbnail

Biogen shares soar as FDA delays decision on aducanumab

pharmaphorum

The FDA has delayed its decision on aducanumab, the troubled Alzheimer’s drug from Biogen and Eisai by three months, raising hopes that it could be approved after all. Biogen’s share price jumped considerably after the news broke at the back end of last week, as an FDA rejection had been on the cards after an overwhelming thumbs-down by the US regulator’s expert advisers late last year.

FDA 70
article thumbnail

Jazz agrees $7.2bn deal to buy cannabis meds pathfinder GW Pharma

pharmaphorum

Jazz Pharma has agreed a $7.2 billion deal to by GW Pharmaceuticals and its pioneering cannabis-derived medicines, headed by childhood epilepsy drug Epidiolex. Nasdaq-listed GW is in line for $220 per share, consisting of $200 in cash and $20 in Jazz stock. That is a sizeable premium on GW’s closing share price of around $147 yesterday, although shares in the company rocketed after the deal was announced to just below the offer price.

FDA 64
article thumbnail

Kaia Health creates new ‘front door’ for MSK pain services

pharmaphorum

Kaia Health is adding to its offering for patients with musculoskeletal (MSK) pain via a partnership with Premium Partners to create a “front door” for patients in the US. The Kaia Gateway is accessed via Kaia Health’s existing MSK programme. Pain management is a controversial issue in the US, where there is an ongoing crisis with over-prescription of opioid painkillers.

64